In our previous investigation, we found out that the simultaneous inhibition of PDE3, PDE4, and PDE7 that are present in T cells may constitute an alternative treatment strategy of T cell-mediated ADs, such as AIH [40,41]. This evidence concerns the gene PDE7A and autoimmune hepatitis.